SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-001809
Filing Date
2021-03-16
Accepted
2021-03-16 07:00:17
Documents
12
Period of Report
2021-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_031621.htm   iXBRL 8-K 29145
  Complete submission text file 0001171843-21-001809.txt   200459

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gbt-20210312.xsd EX-101.SCH 2739
3 XBRL LABEL FILE gbt-20210312_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE gbt-20210312_pre.xml EX-101.PRE 22700
5 EXTRACTED XBRL INSTANCE DOCUMENT f8k_031621_htm.xml XML 3515
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37539 | Film No.: 21743594
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences